We were at the III Spanish Days of Biocatalysis 2021

This week our evolvers were at the IIISPANISH DAYS OF BIOCATALYSIS,  Ivan Mateljak y Javier Viña were talking about our peroxygenase mutants applied for the Pharma & Environmental sector. Besides, our most recent advances in the BBI- BIZENTE PROJECT for thermoset composites biodegradation.

20th Parque Científico de Madrid Anniversary

Our CEO, María Urbano, was invited to speak about the challenges and needs of entrepreneurs together with other entrepreneurs and personalities from the Comunity of Madrid, Fundación para el Conocimiento Madri+d, CSIC, CIEMAT, UAM & UCM. (More info)

EvoEnzyme granted 

EvoEnzyme achieves, together with its partners (REPSOL, IMDEA Energi, ARIEMA Energia y Medioambiente y SEENSO Renoval), one of the two grants awarded by the Community of Madrid in its HUB INNOVACION call.

Interview to Xavi Viña 

Our Science Manager Xavier Viña was  interviewed to talk about BIZENTE Project.” “BIZENTE applies a revolutionary system on composites”. (More info)

EvoEnzyme funded by Torres Quevedo Program

EvoEnzyme has achieved a second grant from theTorres Quevedo program, funded by the Ministry of Science, allowing the company to incorporate a new PhD to its staff!

EVOkit Launching

EvoEnzyme is proudly announcing the release of the EVOkit: the first screening kit in the market carrying a selected collection of laboratory evolved peroxygenases -UPOs- from different fungal species. With a broad activity and selectivity profile, the rapid oxyfunctionalization of complex organic compounds comes true for pharma and chemical processes. (More info)

Our CTO, invited to talk about  innovation 

On the occasion of the visit of the Vice President for Universities, Science and Innovation of the Community of Madrid to the Parque Científico, EvoEnzyme has been selected to present its project as an example of a young company with high technological intensity that is a benchmark in the park. Our CTO, Bernardo Gómez, attended this great event.

EvoEnzyme in BIOTRANS 2021

We are proud to introduce our first Peroxygenase based KIT (EVO -KIT) for the pharma and chemical sectors in the BIOTRANS Conference.

EvoEnzyme with the FECYT 

Our Founder, Miguel Alcalde was interviewed by Fundación Española para la Ciencia y la Tecnología, FECYT. A very interesting event aimed at beneficiaries and managers of Era-CoBiotech projects where Miguel spoke about “Entrepreneurial culture from research”.

Open Expo 21 Maria Urbano

EvoEnzyme in OpenExpo21

Maria Urbano, EvoEnzyme´s CEO, will participate in this great event where she will talk about Entrepreneurship & Sustainability. Don’t miss it!

BIOTRANS

EvoEnzyme in EXPOQUIMIA BIO 

Miguel Alcalde, Founder of EvoEnzyme, participates in EXPOQUIMIA BIO talking about “Green Deal: the path to a climate neutral Europe”. Join us!

EvoEnzyme granted with NEOTEC 

EvoEnzyme selected by the CDTI – Centro para el Desarrollo Tecnológico Industrial as beneficiaries of this prestigious grant program, NEOTEC.

EvoEnzyme 1st PATENT

EvoEnzyme signs an exclusive license agreement with CSIC for the exploitation of evolved peroxygenases (WO/2017/081355 approved in Europe and United States).

EvoEnzyme at TrEnCa 2019

Benicassim, Spain. Miguel Alcalde, EvoEnzyme Founder & Advisor, made an invited lecture introducing the Company.

EvoEnzyme talking about Entrepreneurship

Join us and know the new study of the Fundación para el Conocimiento madri+d , “Startup Radar madri + d”. Our CEO, Maria Urbano, will tell us about EvoEnzyme’s experience undertaking. (More info)

SusChem

Miguel Alcalde in SusChem

Miguel Alcalde, Founder of EvoEnzyme, will participate in the round table on Chemistry and Sustainability during the next SusChem General assembly. 

EvoEnzyme selected for acceleration!

EvoEnzyme has been selected to join the 9th Entrepreneurs Fund Startup Accelerator Program focused on technological projects for energy transition. Our company was selected among 1,275 candidates from 83 different countries. (more info).

 Invited lecture at IQAC

Barcelona, Spain. Miguel Alcalde, EvoEnzyme Founder & Advisor, gave an invited lecture in the seminar program of IQAC.

EVOFARMA Project: the CAM-RIS 3 grant

EvoFarma, the innovative EvoEnzyme´s project, has been granted with a CAM-RIS 3 for young innovative companies from the Community of Madrid and the European Regional development.

EvoEnzyme joins Susplast

EvoEnzyme joins the CSIC Susplast (Interdisciplinary Platform for Sustainable Plastics towards a Circular Economy) to implement plastics management within a circular economy: http://susplast-csic.org

BBI-H2020 BIZENTE Project

EvoEnzyme is participating as a full partner in the 4-year project BIZENTE (H2020-BBI-JTI-2019) aimed at degrading thermoset composites.

EvoEnzyme in COP25

Madrid The CSIC presents at COP25 six technology-based companies to face the challenges of climate change, and EvoEnzyme was one of them!!! (More info).

EvoEnzyme, “Revelation Startup Award 2019”

During “III Inspiring Women Leaders in the digital Era” event in Repsol in Madrid, Women StartupCommunity awarded to EvoEnzyme as the Revelation Startup of 2019.For further information, please visit https://youtu.be/9qfzzR9QB-I

EvoEnzyme collaboration

EvoEnzyme as collaborator of SynCell participated on SynCell2019. An event in which scientists from all over the world were discussing the different applications of artificial cells in health, food, renewable energy and biomaterials. More info in: The European Synthetic Cell Initiative

EvoEnzyme in #WER19

The Women in Entrepeneurship European Roadshow 2019 organized by the European Young Innovators Forum selected Maria Urbano, our CEO and Co-Founder to join this event. She was one of the 300 women, 30 VCs, 10 cities in 1 year.